Photolabeling of the human erythrocyte glucose carrier with androgenic steroids.
Androgenic steroids, which are potent inhibitors of facilitated hexose transport in human erythrocytes, were tested as possible natural photolabels of the hexose carrier protein. Androstenedione, which inhibited 3-O-methylglucose uptake half-maximally at 30-50 microM (EC50), was the most potent inhibitor of the photolabile steroids tested. It appeared to interact directly with the carrier, since it (1) inhibited equilibrium [3H]cytochalasin B binding to high affinity D-glucose-sensitive sites in both intact cells (EC50 = 63 microM) and protein-depleted ghosts (EC50 = 61 microM), (2) inhibited cytochalasin B photolabeling of the band 4.5 carrier region in electrophoretic gels of protein-depleted ghosts (EC50 = 50 microM), and (3) underwent photoincorporation into the same gel region in a D-glucose- and cytochalasin B-sensitive fashion. However, Dixon plots for inhibition of both cytochalasin B binding and transport were upward-curving, indicating the binding of more than one molecule of androstenedione to the carrier. The photoincorporation of androstenedione into band 4.5 protein was both time- and concentration-dependent, and not associated with damage to unlabeled carrier. It probably occurred by activation of the alpha, beta-unsaturated ketone on the steroid rather than indirectly by photoactivation of a group on the carrier protein, as occurs with cytochalasin B. Although androstenedione may bind to more than one region of the carrier, as well as to other non-carrier proteins, tryptic digestion of photolabeled ghosts produced a labeled Mr = 18,000-20,000 fragment, the labeling of which was inhibited by cytochalasin B, and which had an electrophoretic mobility similar to the major labeled tryptic fragment in cytochalasin B-labeled ghosts. These data suggest that androstenedione interacts directly with the hexose carrier and that it or other similar naturally photolabile steroids may serve as useful probes for structural dissection of the carrier protein.
May
J M
JM
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
Danzo
B J
BJ
D019325:3-O-Methylglucose; D000345:Affinity Labels; D000728:Androgens / Q000378:metabolism* / Q000494:pharmacology; D000735:Androstenedione / Q000378:metabolism / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D003571:Cytochalasin B / Q000097:blood; D004912:Erythrocytes / Q000032:analysis*; D006801:Humans; D008757:Methylglucosides / Q000097:blood; D008970:Molecular Weight; D009004:Monosaccharide Transport Proteins / Q000037:antagonists & inhibitors / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood; D010777:Photochemistry; D014357:Trypsin
D000345:Affinity Labels; D000728:Androgens; D001786:Blood Glucose; D001798:Blood Proteins; D008757:Methylglucosides; D009004:Monosaccharide Transport Proteins; D010446:Peptide Fragments; D019325:3-O-Methylglucose; D003571:Cytochalasin B; D000735:Androstenedione; D014357:Trypsin